These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 21150720

  • 1. Systemic immune tuning in renal cell carcinoma: favorable prognostic impact of TGF-β1 mRNA expression in peripheral blood mononuclear cells.
    Busse A, Asemissen A, Nonnenmacher A, Ochsenreither S, Fusi A, Braun F, Stather D, Schmittel A, Miller K, Thiel E, Keilholz U.
    J Immunother; 2011 Jan; 34(1):113-9. PubMed ID: 21150720
    [Abstract] [Full Text] [Related]

  • 2. Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma.
    Busse A, Asemissen AM, Nonnenmacher A, Braun F, Ochsenreither S, Stather D, Fusi A, Schmittel A, Miller K, Thiel E, Keilholz U.
    Eur J Cancer; 2011 Mar; 47(5):690-6. PubMed ID: 21215610
    [Abstract] [Full Text] [Related]

  • 3. Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus.
    Lu LY, Chu JJ, Lu PJ, Sung PK, Hsu CM, Tseng JC.
    J Microbiol Immunol Infect; 2008 Apr; 41(2):165-73. PubMed ID: 18473105
    [Abstract] [Full Text] [Related]

  • 4. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L, Bergmann C, Szczepanski M, Gooding W, Johnson JT, Whiteside TL.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [Abstract] [Full Text] [Related]

  • 5. Role of interleukin-10 and transforming growth factor beta 1 in otitis media with effusion.
    Zhao SQ, Li J, Liu H, Zhang QG, Wang Y, Han DM.
    Chin Med J (Engl); 2009 Sep 20; 122(18):2149-54. PubMed ID: 19781301
    [Abstract] [Full Text] [Related]

  • 6. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS, Krishnadas DK, Agrawal B.
    Int Immunol; 2007 Mar 20; 19(3):227-37. PubMed ID: 17289657
    [Abstract] [Full Text] [Related]

  • 7. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M, Piccirillo CA.
    J Leukoc Biol; 2007 Aug 20; 82(2):335-46. PubMed ID: 17475784
    [Abstract] [Full Text] [Related]

  • 8. Effect of house dust mite immunotherapy on transforming growth factor beta1-producing T cells in asthmatic children.
    Ajduk J, Marinic I, Aberle N, Rabatic S, Gagro A.
    Ann Allergy Asthma Immunol; 2008 Apr 20; 100(4):314-22. PubMed ID: 18450115
    [Abstract] [Full Text] [Related]

  • 9. Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis.
    Xing Q, Su H, Cui J, Wang B.
    Immunol Invest; 2012 Apr 20; 41(1):15-27. PubMed ID: 21563925
    [Abstract] [Full Text] [Related]

  • 10. Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2.
    Berntsen A, Brimnes MK, thor Straten P, Svane IM.
    J Immunother; 2010 May 20; 33(4):425-34. PubMed ID: 20386464
    [Abstract] [Full Text] [Related]

  • 11. Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.
    Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Staehler M, Negrier S, Chevreau C, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Anderson S, Hofilena G, Shan M, Pena C, Lathia C, Bukowski RM.
    J Clin Oncol; 2009 Jul 10; 27(20):3312-8. PubMed ID: 19451442
    [Abstract] [Full Text] [Related]

  • 12. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response?
    Razmkhah M, Jaberipour M, Erfani N, Habibagahi M, Talei AR, Ghaderi A.
    Cell Immunol; 2011 Jul 10; 266(2):116-22. PubMed ID: 20970781
    [Abstract] [Full Text] [Related]

  • 13. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.
    Bergmann C, Strauss L, Zeidler R, Lang S, Whiteside TL.
    Cancer Res; 2007 Sep 15; 67(18):8865-73. PubMed ID: 17875728
    [Abstract] [Full Text] [Related]

  • 14. Human retinal pigment epithelium-induced CD4+CD25+ regulatory T cells suppress activation of intraocular effector T cells.
    Horie S, Sugita S, Futagami Y, Yamada Y, Mochizuki M.
    Clin Immunol; 2010 Jul 15; 136(1):83-95. PubMed ID: 20350837
    [Abstract] [Full Text] [Related]

  • 15. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
    Polimeno M, Napolitano M, Costantini S, Portella L, Esposito A, Capone F, Guerriero E, Trotta A, Zanotta S, Pucci L, Longo N, Perdonà S, Pignata S, Castello G, Scala S.
    BJU Int; 2013 Sep 15; 112(5):686-96. PubMed ID: 23495770
    [Abstract] [Full Text] [Related]

  • 16. Gene expression analysis of the CD4+ T-cell clones derived from gingival tissues of periodontitis patients.
    Ito H, Honda T, Domon H, Oda T, Okui T, Amanuma R, Nakajima T, Yamazaki K.
    Oral Microbiol Immunol; 2005 Dec 15; 20(6):382-6. PubMed ID: 16238600
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice.
    Bank U, Tadje J, Täger M, Wolke C, Bukowska A, Ittenson A, Reinhold D, Helmuth M, Ansorge S, Shakespeare A, Vieth M, Malfertheiner P, Naumann M, Lendeckel U.
    Int J Mol Med; 2007 Oct 15; 20(4):483-92. PubMed ID: 17786278
    [Abstract] [Full Text] [Related]

  • 18. [Changes of CD4+CD25+ regulatory T cells, IL-10 and TGF-beta1 levels in peripheral blood in children with asthma].
    Li M, Song L, Zhang JB, Fang J, Li L.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Oct 15; 11(10):829-32. PubMed ID: 19849943
    [Abstract] [Full Text] [Related]

  • 19. IL-10 and TGF-beta immunoregulatory cytokines rather than natural regulatory T cells are associated with the resolution phase of Vogt-Koyanagi-Harada (VKH) syndrome.
    Commodaro AG, Peron JP, Genre J, Arslanian C, Sanches L, Muccioli C, Rizzo LV, Belfort R.
    Scand J Immunol; 2010 Jul 15; 72(1):31-7. PubMed ID: 20591073
    [Abstract] [Full Text] [Related]

  • 20. Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.
    Wang LH, Lin YH, Yang J, Guo W.
    Int Arch Allergy Immunol; 2009 Jul 15; 148(3):199-210. PubMed ID: 18849611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.